Central Dysmyelination in SSADH‐Deficient Humans and Mice
Annals of Clinical and Translational Neurology · 2025
DOI: 10.1002/acn3.70148 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Itay Tokatly Latzer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Amino Acid Metabolism, Inborn Errors, Brain, Demyelinating Diseases, gamma-Aminobutyric Acid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Objectives
Succinic semialdehyde dehydrogenase deficiency (SSADHD) is an inherited metabolic disorder characterized by an accumulation of γ‐aminobutyric (GABA). In addition to its synaptic role as an inhibitory neurotransmitter, GABA also plays an important role in myelination. We aimed to investigate the relationship between GABA and myelination abnormalities in SSADHD patients and the mouse model.
Methods
Brain MRIs performed on 44 individuals (23 with SSADHD and 21 healthy controls) were independently reviewed by two neuroradiologists and scored using a disease‐specific myelination scoring system. Inter‐rater reliability (IRR) was assessed by the intraclass correlation coefficient. Myelination scores of SSADHD individuals were correlated with clinical, biochemical, magnetic resonance spectroscopy, and genetic data. Additionally, we investigated the expression of myelin‐related genes in a mouse SSADHD model.
Results
Dysmyelination in SSADHD patients was overall mild, but significantly greater than in healthy controls ( p < 0.001). In SSADHD patients, lower myelination scores were significantly correlated with younger age ( R = 0.775, p < 0.001) and higher plasma GABA ( R = −0.722, p < 0.001) and γ‐hydroxybutyric acid (GHB) ( R = −0.683, p = 0.001). In SSADH‐deficient mice, there was reduced expression of genes encoding myelin basic protein ( p = 0.001), myelin‐associated oligodendrocyte basic protein ( p = 0.001), and mitochondrial aspartate transporter ( p = 0.025).
Interpretation
Excessive GABA and GHB, which characterize SSADHD and are further pronounced in younger SSADHD individuals, may account for delayed oligodendrocyte maturation and altered myelination dynamics in this disorder. Studying the properties of dysmyelination in this unique disorder enhances our understanding of GABA's mediating role on myelination and may contribute to monitoring disease progression and managing other white‐matter neurological disorders. Trial Registration NCT03758521
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- School of Medicine, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel Aviv, Israel.
- Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Boston, Massachusetts, USA.
- F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, Massachusetts, USA.
- Department of Radiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
ORCID-Profile: Itay Tokatly Latzer, Henry H C Lee, Mariarita Bertoldi, Alexander Rotenberg, Jean-Baptiste Roullet, Phillip L Pearl
Förderung
- NICHD NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Tokatly Latzer, I., Lee, H. H. C., Yang, E., Alves, C., Bertoldi, M., Fung, C., Steele, S. V., Kule, E., Jin, Z., Rotenberg, A., Roullet, J. B., & Pearl, P. L. (2025). Central Dysmyelination in SSADH‐Deficient Humans and Mice. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70148
Vancouver
Tokatly Latzer I, Lee HHC, Yang E, Alves C, Bertoldi M, Fung C, et al. Central Dysmyelination in SSADH‐Deficient Humans and Mice. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.70148
BibTeX
@article{TokatlyLatzer2025,
author = {Tokatly Latzer, Itay and Lee, Henry H C and Yang, Edward and Alves, Cesar and Bertoldi, Mariarita and Fung, Caitlyn and Steele, Spencer V and Kule, Eren and Jin, Zijie and Rotenberg, Alexander and Roullet, Jean-Baptiste and Pearl, Phillip L},
title = {Central Dysmyelination in SSADH‐Deficient Humans and Mice},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
doi = {10.1002/acn3.70148}
}
EUVIMED